Schizophrenia trials in Czechia

4 of 5 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  Where

  Brno-Stred, Choceň, Pardubice I, Prague

  Age

  55 years to 90 years

  People

  300 worldwide

  Run by

  MapLight Therapeutics

  See details and how to joinNCT06887192 · EU 2024-519820-26-00
• Phase 2Enrolling by invitation
  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  Where

  Brno-Stred, Choceň, Pardubice I, Prague

  Age

  55 years to 91 years

  People

  210 worldwide

  Run by

  MapLight Therapeutics

  See details and how to joinNCT07459660 · EU 2025-521757-16-00
• Phase 2Taking people
  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  Where

  Brno, Hradec Králové, Prague

  Age

  55 years and over

  People

  370 worldwide

  Run by

  Intra-Cellular Therapies, Inc.

  See details and how to joinNCT06540833
• Phase 3Taking people
  Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  Where

  Brno, Klecany

  Age

  18 years to 65 years

  People

  472 worldwide

  Run by

  Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  See details and how to joinNCT07686263 · EU 2025-523664-20-00